Loading...

Amneal Pharmaceuticals, Inc. Peer Comparison

Metric Value Ranking
Market Cap $3.6 Billion 4/18 ITCI
$13.6B
NBIX
$11.5B
ALKS
$5.8B
AMRX
$3.6B
DCPH
$2.2B
DVAX
$1.7B
AMPH
$1.5B
ANIP
$1.2B
PAHC
$1.0B
COLL
$956.5M
EOLS
$933.4M
IRWD
$307.3M
PROC
$114.0M
ASRT
$80.2M
SSIC
$66.7M
EGRX
$15.2M
ACRX
$14.6M
AGRX
$10.4M
Gross Margin 38% 17/18 IRWD
100%
ANIP
100%
ACRX
100%
SSIC
100%
NBIX
99%
DCPH
92%
ITCI
91%
DVAX
84%
ALKS
83%
EGRX
74%
ASRT
74%
AGRX
73%
EOLS
70%
COLL
61%
PROC
58%
AMPH
54%
AMRX
38%
PAHC
32%
Profit Margin 2% 11/18 SSIC
67%
IRWD
34%
ALKS
24%
DVAX
22%
NBIX
21%
AMPH
21%
EGRX
8%
PROC
7%
COLL
6%
PAHC
3%
AMRX
2%
ASRT
-10%
ITCI
-15%
ANIP
-16%
EOLS
-32%
ACRX
-100%
AGRX
-100%
DCPH
-100%
EBITDA margin 13% 10/18 SSIC
147534%
NBIX
31%
AMPH
30%
IRWD
28%
ALKS
28%
COLL
22%
ANIP
20%
EGRX
17%
PROC
14%
AMRX
13%
DVAX
13%
PAHC
10%
ASRT
-10%
ITCI
-22%
EOLS
-38%
AGRX
-49%
DCPH
-105%
ACRX
-1210%
Quarterly Revenue $702.5 Million 1/18 AMRX
$702.5M
NBIX
$622.1M
ALKS
$378.1M
PAHC
$260.4M
AMPH
$188.8M
ITCI
$175.2M
COLL
$159.3M
ANIP
$148.3M
PROC
$118.4M
IRWD
$91.6M
DVAX
$79.3M
EGRX
$64.6M
EOLS
$60.2M
DCPH
$45.0M
ASRT
$29.2M
AGRX
$5.6M
SSIC
$1.9M
ACRX
$117,000
Quarterly Earnings $11.8 Million 6/18 NBIX
$129.8M
ALKS
$92.4M
AMPH
$40.4M
IRWD
$31.1M
DVAX
$17.6M
AMRX
$11.8M
COLL
$9.3M
PROC
$8.2M
PAHC
$7.0M
EGRX
$5.2M
SSIC
$1.3M
ACRX
-$1.4M
ASRT
-$2.8M
AGRX
-$11.9M
EOLS
-$19.2M
ANIP
-$24.2M
ITCI
-$26.3M
DCPH
-$45.1M
Quarterly Free Cash Flow $0 Million 9/18 NBIX
$149.9M
ALKS
$97.0M
AMPH
$46.2M
PROC
$39.7M
ANIP
$21.5M
DVAX
$18.1M
PAHC
$3.0M
SSIC
$840,198
AMRX
-$0
IRWD
-$0
AGRX
-$0
ASRT
-$35,000
EGRX
-$132,000
ACRX
-$3.0M
EOLS
-$4.7M
COLL
-$9.2M
ITCI
-$27.2M
DCPH
-$54.7M
Trailing 4 Quarters Revenue $2.7 Billion 1/18 AMRX
$2.7B
NBIX
$2.2B
ALKS
$1.5B
PAHC
$1.0B
AMPH
$698.7M
ITCI
$612.9M
COLL
$599.2M
ANIP
$555.5M
PROC
$414.1M
IRWD
$378.4M
DVAX
$259.5M
EGRX
$257.6M
EOLS
$245.7M
DCPH
$174.9M
ASRT
$125.8M
AGRX
$21.6M
SSIC
$7.8M
ACRX
$369,000
Trailing 4 Quarters Earnings -$161.7 Million 17/18 AMRX
$702.5M
NBIX
$622.1M
ALKS
$378.1M
PAHC
$260.4M
AMPH
$188.8M
ITCI
$175.2M
COLL
$159.3M
ANIP
$148.3M
PROC
$118.4M
IRWD
$91.6M
DVAX
$79.3M
EGRX
$64.6M
EOLS
$60.2M
DCPH
$45.0M
ASRT
$29.2M
AGRX
$5.6M
SSIC
$1.9M
ACRX
$117,000
Quarterly Earnings Growth 21% 10/18 PAHC
187%
EGRX
155%
SSIC
128%
IRWD
103%
ASRT
99%
ALKS
93%
ACRX
80%
NBIX
56%
DVAX
23%
AMRX
21%
DCPH
2%
ITCI
-9%
EOLS
-13%
AMPH
-18%
COLL
-55%
PROC
-64%
AGRX
-212%
ANIP
-343%
Annual Earnings Growth -456% 18/18 PROC
2764%
SSIC
352%
IRWD
103%
ASRT
73%
COLL
49%
ITCI
43%
AMPH
24%
EOLS
22%
NBIX
4%
DVAX
0%
DCPH
-4%
AGRX
-8%
PAHC
-34%
ALKS
-50%
EGRX
-87%
ACRX
-104%
ANIP
-125%
AMRX
-456%
Quarterly Revenue Growth 13% 8/18 SSIC
77%
ITCI
39%
DCPH
35%
NBIX
25%
EOLS
22%
COLL
17%
DVAX
14%
AMRX
13%
ANIP
13%
PAHC
13%
PROC
7%
AMPH
5%
AGRX
1%
ALKS
-1%
EGRX
-13%
ASRT
-18%
IRWD
-19%
ACRX
-77%
Annual Revenue Growth 11% 9/18 SSIC
134%
ITCI
34%
AGRX
27%
EOLS
25%
DCPH
23%
NBIX
21%
ANIP
15%
AMPH
13%
AMRX
11%
COLL
10%
PAHC
5%
DVAX
4%
PROC
-7%
IRWD
-13%
ASRT
-21%
ALKS
-33%
EGRX
-39%
ACRX
-83%
Cash On Hand $74.0 Million 10/18 ITCI
$464.3M
ALKS
$396.3M
NBIX
$349.1M
AMPH
$192.1M
ANIP
$145.0M
DVAX
$119.3M
DCPH
$91.2M
IRWD
$88.2M
EOLS
$85.0M
AMRX
$74.0M
PAHC
$51.8M
COLL
$39.0M
ASRT
$38.0M
SSIC
$29.8M
PROC
$17.6M
EGRX
$15.4M
ACRX
$13.4M
AGRX
$2.8M
Short Term Debt $241.0 Million 1/18 AMRX
$241.0M
PROC
$69.2M
COLL
$65.9M
NBIX
$34.8M
ALKS
$9.2M
EGRX
$8.3M
ANIP
$7.2M
AMPH
$4.5M
ITCI
$4.2M
DCPH
$3.6M
IRWD
$3.2M
EOLS
$1.6M
AGRX
$289,000
DVAX
-$0
PAHC
-$0
ACRX
-$0
ASRT
-$0
SSIC
-$0
Long Term Debt $2.3 Billion 1/18 AMRX
$2.3B
COLL
$808.5M
AMPH
$625.4M
ANIP
$618.2M
ALKS
$356.9M
PAHC
$287.7M
NBIX
$251.4M
DVAX
$250.2M
PROC
$220.7M
IRWD
$211.7M
EGRX
$61.9M
ASRT
$38.8M
DCPH
$21.4M
ITCI
$13.5M
EOLS
$7.1M
ACRX
$0
AGRX
$0
SSIC
$0
PE -1.00 11/18 DVAX
68.72
PAHC
59.97
NBIX
29.72
ALKS
15.31
SSIC
12.36
COLL
10.80
AMPH
9.46
IRWD
3.47
PROC
2.18
EGRX
0.97
AMRX
-1.00
ITCI
-1.00
ANIP
-1.00
ACRX
-1.00
AGRX
-1.00
DCPH
-1.00
EOLS
-1.00
ASRT
-1.00
PS 1.33 12/18 ACRX
39.51
ITCI
22.16
DCPH
12.65
SSIC
8.60
DVAX
6.49
NBIX
5.11
ALKS
3.88
EOLS
3.80
ANIP
2.23
AMPH
2.13
COLL
1.60
AMRX
1.33
PAHC
1.00
IRWD
0.81
ASRT
0.64
AGRX
0.48
PROC
0.28
EGRX
0.06
PB 0.00 17/18 EOLS
158.47
ITCI
11.86
DCPH
7.00
ALKS
4.52
NBIX
4.22
COLL
4.08
PAHC
4.04
PROC
2.96
ANIP
2.87
DVAX
2.47
IRWD
2.39
AMPH
2.05
ACRX
0.80
SSIC
0.75
ASRT
0.61
EGRX
0.06
AMRX
0.00
AGRX
0.00
PC 48.25 1/18 AMRX
48.25
NBIX
32.85
ITCI
29.25
COLL
24.55
DCPH
24.26
PAHC
20.14
ALKS
14.73
DVAX
14.12
EOLS
10.98
ANIP
8.54
AMPH
7.76
PROC
6.49
AGRX
3.66
IRWD
3.48
SSIC
2.24
ASRT
2.11
ACRX
1.09
EGRX
0.99
Liabilities to Equity 0.00 16/18 EOLS
37.98
PROC
11.68
COLL
5.98
PAHC
2.74
ANIP
2.11
IRWD
2.03
AMPH
1.12
ASRT
1.11
ALKS
0.67
EGRX
0.61
DVAX
0.56
DCPH
0.33
NBIX
0.30
ACRX
0.27
ITCI
0.16
AMRX
0.00
AGRX
0.00
SSIC
0.00
ROA -0.05 12/18 IRWD
23%
ALKS
18%
NBIX
11%
AMPH
10%
PROC
10%
SSIC
6%
COLL
5%
EGRX
4%
DVAX
2%
PAHC
2%
ANIP
-1%
AMRX
-5%
ITCI
-7%
EOLS
-24%
ASRT
-25%
ACRX
-34%
DCPH
-45%
AGRX
-106%
ROE 1.73 1/18 AMRX
173%
PROC
133%
AGRX
72%
IRWD
69%
COLL
38%
ALKS
29%
AMPH
22%
NBIX
14%
PAHC
7%
EGRX
6%
SSIC
6%
DVAX
4%
ANIP
-2%
ITCI
-8%
ACRX
-43%
ASRT
-52%
DCPH
-60%
EOLS
-942%
Current Ratio 0.97 16/18 ITCI
7.37
ACRX
4.70
NBIX
4.33
DCPH
4.01
DVAX
2.79
EGRX
2.65
ALKS
2.50
ASRT
1.90
AMPH
1.89
ANIP
1.50
IRWD
1.49
PAHC
1.37
COLL
1.17
PROC
1.08
EOLS
1.03
AMRX
0.97
AGRX
0.41
SSIC
-1.00
Quick Ratio 0.02 17/18 DVAX
68.72
PAHC
59.97
NBIX
29.72
ALKS
15.31
SSIC
12.36
COLL
10.80
AMPH
9.46
IRWD
3.47
PROC
2.18
EGRX
0.97
AMRX
-1.00
ITCI
-1.00
ANIP
-1.00
ACRX
-1.00
AGRX
-1.00
DCPH
-1.00
EOLS
-1.00
ASRT
-1.00
Long Term Debt to Equity -24.19 18/18 PROC}
5.60
COLL}
3.45
IRWD}
1.65
ANIP}
1.52
EOLS}
1.20
PAHC}
1.11
AMPH}
0.86
DVAX}
0.37
ASRT}
0.30
ALKS}
0.28
EGRX}
0.25
NBIX}
0.09
DCPH}
0.07
ITCI}
0.01
ACRX}
0.00
AGRX}
0.00
SSIC}
0.00
AMRX}
-24.19
Debt to Equity -26.77 18/18 PROC
7.36
COLL
3.73
IRWD
1.67
ANIP
1.54
EOLS
1.47
PAHC
1.11
AMPH
0.87
DVAX
0.37
ASRT
0.30
EGRX
0.28
ALKS
0.28
NBIX
0.09
DCPH
0.08
ITCI
0.02
ACRX
0.00
SSIC
0.00
AGRX
-0.01
AMRX
-26.77
Burn Rate 0.53 10/18 ITCI
16.63
PAHC
11.44
ACRX
9.87
ASRT
8.66
EOLS
4.28
ANIP
2.86
DCPH
1.95
COLL
0.99
PROC
0.98
AMRX
0.53
AGRX
0.24
NBIX
-3.14
IRWD
-4.04
ALKS
-5.23
AMPH
-13.44
DVAX
-15.73
SSIC
-23.41
EGRX
-25.01
Cash to Cap 0.02 18/18 EGRX
1.01
ACRX
0.92
ASRT
0.47
SSIC
0.45
IRWD
0.29
AGRX
0.27
PROC
0.15
AMPH
0.13
ANIP
0.12
EOLS
0.09
DVAX
0.07
ALKS
0.07
PAHC
0.05
COLL
0.04
DCPH
0.04
NBIX
0.03
ITCI
0.03
AMRX
0.02
CCR 0.00 13/18 PROC
4.85
ACRX
2.18
DCPH
1.21
NBIX
1.15
AMPH
1.14
ALKS
1.05
DVAX
1.03
ITCI
1.03
SSIC
0.66
PAHC
0.44
EOLS
0.25
ASRT
0.01
AMRX
0.00
IRWD
0.00
AGRX
0.00
EGRX
-0.03
ANIP
-0.89
COLL
-0.99
EV to EBITDA 67.58 2/18 DVAX}
180.13
AMRX}
67.58
NBIX}
59.44
ANIP}
58.77
ALKS}
55.42
COLL}
51.44
PAHC}
47.75
AMPH}
33.82
PROC}
23.63
IRWD}
16.93
EGRX}
6.51
SSIC}
0.01
ACRX}
-0.84
AGRX}
-2.86
ASRT}
-26.59
EOLS}
-37.73
DCPH}
-45.43
ITCI}
-339.27
EV to Revenue 2.24 12/18 ITCI
21.43
DCPH
12.27
DVAX
7.00
NBIX
5.07
SSIC
4.76
ALKS
3.86
EOLS
3.49
ACRX
3.22
ANIP
3.09
COLL
2.99
AMPH
2.76
AMRX
2.24
PAHC
1.22
IRWD
1.15
PROC
0.93
ASRT
0.64
AGRX
0.36
EGRX
0.27